Grant C. Bogle — Chief Commercial Officer and Senior Vice President at TESARO

Mr. Grant C. Bogle has been Chief Commercial Officer and Senior Vice President at Tesaro, Inc. since July 13, 2015. Mr. Bogle has more than twenty-five years of experience in a variety of commercial roles within the biopharmaceutical industry. Mr. Bogle served as an Executive Vice President of Integrated Oncology Solutions at US Oncology, Inc. and US Oncology Holdings, Inc. since July 1, 2009. Mr. Bogle joined US Oncology Holdings in June 2007, as Senior Vice President, Regional Operations for the Northeast region. Mr. Bogle served as Senior Vice President of Pharmaceutical and Biotech Solutions at McKesson Specialty Health, where he led the informatics, health economics and outcomes research, reimbursement access and safety services and U.S. Oncology Clinical Research business units. He served as Senior Vice President of Sales & Marketing for VELCADE(R) (bortezomib) for Injection of Millennium Pharmaceuticals, Inc. since January 25, 2006 and served as its Vice President of Sales and Marketing for INTEGRILIN(R) (eptifibatide) Injection from 2004 to January 25, 2006. Prior to serving with Millennium from 2004 to 2007, Mr. Bogle served as President of ViaCord, the blood- banking division of ViaCell, Inc. in Boston. He served as Executive Vice President, Strategy and Emerging Businesses at US Oncology, Inc. He served as President of ViaCell Commercial Operations of ViaCell Inc. since 2002 until March 31, 2004. Mr. Bogle served with Knoll Pharmaceutical Company from 1997 to 2001 and Roche Pharmaceuticals from 2001 to 2002. Mr. Bogle held senior sales and marketing roles with DuPont and American Critical Care (a division of American Hospital Supply Corp). He holds MBA from Columbia University and undergraduate degree in economics from Dartmouth College.